Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Sci. STKE, 6 November 2001
Vol. 2001, Issue 107, p. pe39
[DOI: 10.1126/stke.2001.107.pe39]

PERSPECTIVES

Melatonin Receptor Signaling: Finding the Path Through the Dark

Monica I. Masana1 and Margarita L. Dubocovich2

1Department of Molecular Pharmacology and Biological Chemistry, Northwestern University Medical School, Chicago, IL 60611, USA.
2 Department of Molecular Pharmacology and Biological Chemistry, Department of Psychiatry and Behavioral Sciences, Northwestern Drug Discovery Program, Northwestern University Institute for Neuroscience, Northwestern University Medical School, Chicago, IL 60611, USA.

Abstract: Melatonin, dubbed "the hormone of darkness," is involved in relaying photoperiodic information to the organism. Not only is melatonin involved in the regulation of circadian rhythms and sleep, but it also has roles in visual, cerebrovascular, reproductive, neuroendocrine, and neuroimmunological functions. Melatonin mediates its effects through G protein-coupled receptors: MT1, MT2, and, possibly, MT3. Pharmacological agents have been instrumental in identifying these receptor types. Masana and Dubocovich discuss how the level of receptor expression may alter their efficacy, so that caution is necessary when extrapolating the pharmacological properties of ligands defined on recombinant systems to the receptors in the organism. With these cautions in mind, they describe the various signaling pathways and physiological roles ascribed to the three melatonin receptor types.

Corresponding author: Department of Molecular Pharmacology and Biological Chemistry (S-215), Northwestern University Medical School, 303 E. Chicago Avenue, Chicago, IL 60611, USA. Telephone: 312-503-8005, fax: 312-503-2334, e-mail: mdubo{at}northwestern.edu

Citation: M. I. Masana, M. L. Dubocovich, Melatonin Receptor Signaling: Finding the Path Through the Dark. Sci. STKE 2001, pe39 (2001).

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, Classification, and Pharmacology of G Protein-Coupled Melatonin Receptors.
M. L. Dubocovich, P. Delagrange, D. N. Krause, D. Sugden, D. P. Cardinali, and J. Olcese (2010)
Pharmacol. Rev. 62, 343-380
   Abstract »    Full Text »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882